Oramed Pharmaceuticals Inc. Logo

Oramed Pharmaceuticals Inc.

Develops oral drug delivery systems to turn injectable drugs, like insulin, into oral therapies.

ORMP | TA

Overview

Corporate Details

ISIN(s):
US68403P2039
LEI:
Country:
Israel
Address:
20 Mamilla Avenue, 9414904 Jerusalem
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Oramed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company specializing in the development of oral drug delivery systems. Established in 2006, the company leverages its proprietary platform technology to transform injectable drugs into oral therapies, aiming to enhance patient comfort, compliance, and safety. Its flagship product is an oral insulin capsule for the treatment of type 2 diabetes, which has undergone extensive clinical development. Oramed's primary focus is on providing non-invasive alternatives to injected medications, particularly for chronic conditions like diabetes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-22 09:42
Post-Annual General Meeting Information
Other Report or Announcement
English 118.7 KB
2025-08-22 09:42
Foreign Filer Report
Other Report or Announcement
English 36.4 KB
2025-08-22 09:41
Registration Form
Other Report or Announcement
English 181.3 KB
2025-08-22 09:41
Foreign Filer Report
Other Report or Announcement
English 36.4 KB
2025-08-17 15:18
Foreign Filer Report
FORM 10-Q- FINANCIAL STATEMENTS AS OF JUNE 30, 2025
English 36.4 KB
2025-08-17 15:16
Major Shareholding Notification
Form 13G
English 93.7 KB
2025-08-17 15:16
Foreign Filer Report
Form 13G
English 36.4 KB
2025-07-23 17:53
Delisting Announcement
Option Agreement for the Repurchase of Warrants
English 316.7 KB
2025-07-23 17:53
Foreign Filer Report
Option Agreement for the Repurchase of Warrants
English 36.4 KB
2025-07-18 14:52
Proxy Solicitation & Information Statement
Other Report or Announcement
English 1.4 MB
2025-07-18 14:52
Proxy Solicitation & Information Statement
Other Report or Announcement
English 36.4 KB
2025-07-18 14:51
Registration Form
Other Report or Announcement
English 448.1 KB
2025-07-18 14:51
Registration Form
Other Report or Announcement
English 36.4 KB
2025-07-18 14:50
Annual / Quarterly Financial Statement
Other Report or Announcement
English 359.9 KB
2025-07-18 14:50
Foreign Filer Report
Other Report or Announcement
English 36.4 KB

Automate Your Workflow. Get a real-time feed of all Oramed Pharmaceuticals Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Oramed Pharmaceuticals Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.